Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Allergy
Published in: Clinical and Translational Allergy 1/2017

Open Access 01-12-2017 | Review

Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews

Authors: Felix Asamoah, Artemisia Kakourou, Sangeeta Dhami, Susanne Lau, Ioana Agache, Antonella Muraro, Graham Roberts, Cezmi Akdis, Matteo Bonini, Ozlem Cavkaytar, Breda Flood, Kenji Izuhara, Marek Jutel, Ömer Kalayci, Oliver Pfaar, Aziz Sheikh

Published in: Clinical and Translational Allergy | Issue 1/2017

Login to get access

Abstract

Background

There is clinical uncertainty about the effectiveness and safety of allergen immunotherapy (AIT) for the treatment of allergic asthma.

Objectives

To undertake a systematic overview of the effectiveness, cost-effectiveness and safety of AIT for the treatment of allergic asthma.

Methods

We searched nine electronic databases from inception to October 31, 2015. Systematic reviews were independently screened by two reviewers against pre-defined eligibility criteria and critically appraised using the Critical Appraisal Skills Programme quality assessment tool for systematic reviews. Data were descriptively and thematically synthesized.

Results

We identified nine eligible systematic reviews; these focused on delivery of AIT through the following routes: subcutaneous (SCIT; n = 3); sublingual (SLIT; n = 4); and both SCIT and SLIT (n = 2). This evidence found that AIT delivered by SCIT and SLIT can improve medication and symptom scores and measures of bronchial hyper-reactivity. The impact on measures of lung function or asthma control was however less clear. We found no systematic review level evidence on the cost-effectiveness of SCIT or SLIT. SLIT had a favorable safety profile when compared to SCIT, particularly in relation to the risk of systemic reactions.

Conclusions

AIT has the potential to achieve reductions in symptom and medication scores, but there is no clear or consistent evidence that measures of lung function can be improved. Bearing in mind the limitations of synthesizing evidence from systematic reviews and the fact that these reviews include mainly dated studies, a systematic review of current primary studies is now needed to update this evidence base, estimate the effectiveness of AIT on asthma outcomes and to investigate the relative effectiveness, cost-effectiveness and safety of SCIT and SLIT.
Appendix
Available only for authorised users
Literature
1.
2.
Organization WH. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach; 2007.
3.
Papadopoulos NG, Arakawa H, Carlsen K-H, Custovic A, Gern J, Lemanske R, et al. International consensus on (ICON) pediatric asthma. Allergy. 2012;67:976–97.CrossRefPubMedPubMedCentral
4.
5.
Gough H, Grabenhenrich L, Reich A, Eckers N, Nitsche O, Schramm D. Allergic multimorbidity of asthma, rhinitis and eczema over 20 years in the German birth cohort MAS. Pediatr Allergy Immunol. 2015;26(5):431–7.CrossRefPubMedPubMedCentral
6.
7.
Dhami S, et al. Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clin Transl Allergy. 2015;6:5.CrossRefPubMed
8.
9.
Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2010;8:CD001186.
10.
Calamita Z, et al. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy. 2006;61(10):1162–72.CrossRefPubMed
11.
Chelladurai Y, et al. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. J Allergy Clin Immunol Pract. 2013;1(4):361–9.CrossRefPubMed
12.
Compalati E, et al. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy. 2009;64(11):1570–9.CrossRefPubMed
13.
Erekosima N, et al. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review. Laryngoscope. 2014;124(3):616–27.CrossRefPubMed
14.
Normansell R, Kew KM, Bridgman AL. Sublingual immunotherapy for asthma. Cochrane Database Syst Rev. 2015;8:CD011293.
15.
Tao L, et al. Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomized, double-blind and placebo-controlled trials. Clin Respir J. 2014;8(2):192–205.CrossRefPubMed
16.
Polzehl D, Keck T, Riechelmann H. Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma. Laryngorhinootologie. 2003;82(4):272–80.CrossRefPubMed
17.
Kim J, Lin S, Suarez-Cuervo C, Chelladurai Y, Ramanathan M, Segal J, Erekosima N. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review PEDIATRICS, Vol 131, Number 6; 2013.
18.
Shaikh WA. Immunotherapy vs inhaled budesonide in bronchial asthma: an open, parallel, comparative trial. Clin Exp Allergy. 1997;27(11):1279–84.CrossRefPubMed
19.
Maestrelli P, et al. Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite. J Allergy Clin Immunol. 2004;113(4):643–9.CrossRefPubMed
20.
Olsen OT, et al. A 1-year, placebo-controlled, double-blind house-dust-mite immunotherapy study in asthmatic adults. Allergy. 1997;52(8):853–9.CrossRefPubMed
21.
Pichler CE, et al. Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity. Allergy. 1997;52(3):274–83.CrossRefPubMed
22.
Wang H, et al. A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients. Allergy. 2006;61(2):191–7.CrossRefPubMed
23.
Bousquet J, et al. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. J Allergy Clin Immunol. 1988;82(6):971–7.CrossRefPubMed
24.
Kohno Y, et al. Effect of rush immunotherapy on airway inflammation and airway hyperresponsiveness after bronchoprovocation with allergen in asthma. J Allergy Clin Immunol. 1998;102(6 Pt 1):927–34.CrossRefPubMed
25.
Nouri-Aria KT, et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol. 2004;172(5):3252–9.CrossRefPubMed
26.
27.
Ohman JL Jr, Findlay SR, Leitermann KM. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses. J Allergy Clin Immunol. 1984;74(3 Pt 1):230–9.CrossRefPubMed
28.
Malling HJ, Dreborg S, Weeke B. Diagnosis and immunotherapy of mould allergy. III. Diagnosis of Cladosporium allergy by means of symptom score, bronchial provocation test, skin prick test, RAST, CRIE and histamine release. Allergy. 1986;41(1):57–67.CrossRefPubMed
29.
Rak S, et al. A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma. J Allergy Clin Immunol. 2001;108(6):921–8.CrossRefPubMed
30.
Malling HJ. Diagnosis and immunotherapy of mould allergy. IV. Relation between asthma symptoms, spore counts and diagnostic tests. Allergy. 1986;41(5):342–50.CrossRefPubMed
Metadata
Title
Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews
Authors
Felix Asamoah
Artemisia Kakourou
Sangeeta Dhami
Susanne Lau
Ioana Agache
Antonella Muraro
Graham Roberts
Cezmi Akdis
Matteo Bonini
Ozlem Cavkaytar
Breda Flood
Kenji Izuhara
Marek Jutel
Ömer Kalayci
Oliver Pfaar
Aziz Sheikh
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Clinical and Translational Allergy / Issue 1/2017
Electronic ISSN: 2045-7022
DOI
https://doi.org/10.1186/s13601-017-0160-0

Other articles of this Issue 1/2017

Clinical and Translational Allergy 1/2017 Go to the issue

Research

Early childhood risk factors for rhinoconjunctivitis in adolescence: a prospective birth cohort study

Study protocol

An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension

Erratum

Erratum to: Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review

Brief communication

National clinical practice guidelines for food allergy and anaphylaxis: an international assessment

Brief communication

Idiopathic non-histaminergic acquired angioedema: a case series and discussion of published clinical trials

Brief communication

Low percentage of clinically relevant pistachio nut and mango co-sensitisation in cashew nut sensitised children